Literature DB >> 12665579

Caspase-dependent cleavage of c-Abl contributes to apoptosis.

Daniela Barilà1, Alessandra Rufini, Ivano Condò, Natascia Ventura, Karel Dorey, Giulio Superti-Furga, Roberto Testi.   

Abstract

The nonreceptor tyrosine kinase c-Abl may contribute to the regulation of apoptosis. c-Abl activity is induced in the nucleus upon DNA damage, and its activation is required for execution of the apoptotic program. Recently, activation of nuclear c-Abl during death receptor-induced apoptosis has been reported; however, the mechanism remains largely obscure. Here we show that c-Abl is cleaved by caspases during tumor necrosis factor- and Fas receptor-induced apoptosis. Cleavage at the very C-terminal region of c-Abl occurs mainly in the cytoplasmic compartment and generates a 120-kDa fragment that lacks the nuclear export signal and the actin-binding region but retains the intact kinase domain, the three nuclear localization signals, and the DNA-binding domain. Upon caspase cleavage, the 120-kDa fragment accumulates in the nucleus. Transient-transfection experiments show that cleavage of c-Abl may affect the efficiency of Fas-induced cell death. These data reveal a novel mechanism by which caspases can recruit c-Abl to the nuclear compartment and to the mammalian apoptotic program.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665579      PMCID: PMC152541          DOI: 10.1128/MCB.23.8.2790-2799.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Caspase structure, proteolytic substrates, and function during apoptotic cell death.

Authors:  D W Nicholson
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

Review 2.  Caspases - controlling intracellular signals by protease zymogen activation.

Authors:  H R Stennicke; G S Salvesen
Journal:  Biochim Biophys Acta       Date:  2000-03-07

3.  Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells.

Authors:  M Lobo; I Zachary
Journal:  Biochem Biophys Res Commun       Date:  2000-10-05       Impact factor: 3.575

Review 4.  SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl.

Authors:  S M Feller; R Ren; H Hanafusa; D Baltimore
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

5.  Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations.

Authors:  P L Schwartzberg; A M Stall; J D Hardin; K S Bowdish; T Humaran; S Boast; M L Harbison; E J Robertson; S P Goff
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

6.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

7.  Regulation of the Fas apoptotic cell death pathway by Abl.

Authors:  A J McGahon; W K Nishioka; S J Martin; A Mahboubi; T G Cotter; D R Green
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

8.  Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase.

Authors:  Y J Miao; J Y Wang
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

9.  The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

Authors:  S T Wen; P K Jackson; R A Van Etten
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

10.  The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.

Authors:  R A Van Etten; P K Jackson; D Baltimore; M C Sanders; P T Matsudaira; P A Janmey
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  28 in total

1.  The c-Abl expression in uterine epithelium during the mouse estrus cycle.

Authors:  A Yaba Ucar; U A Kayisli; N Demir
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

Review 2.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

Review 3.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

Review 4.  c-Abl in neurodegenerative disease.

Authors:  Sarah D Schlatterer; Christopher M Acker; Peter Davies
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

5.  c-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization.

Authors:  Maria Giovanna di Bari; Laura Ciuffini; Michele Mingardi; Roberto Testi; Silvia Soddu; Daniela Barilà
Journal:  EMBO Rep       Date:  2006-04-28       Impact factor: 8.807

6.  Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.

Authors:  Xiaohui Zhang; Pengfei Li; Junying Bao; Santo V Nicosia; Honggang Wang; Steven A Enkemann; Wenlong Bai
Journal:  J Biol Chem       Date:  2005-08-10       Impact factor: 5.157

7.  High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.

Authors:  Veronika Kanderova; Daniela Kuzilkova; Jan Stuchly; Martina Vaskova; Tomas Brdicka; Karel Fiser; Ondrej Hrusak; Fridtjof Lund-Johansen; Tomas Kalina
Journal:  Mol Cell Proteomics       Date:  2016-01-19       Impact factor: 5.911

8.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

9.  Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism.

Authors:  H Zhang; D Trachootham; W Lu; J Carew; F J Giles; M J Keating; R B Arlinghaus; P Huang
Journal:  Leukemia       Date:  2008-04-03       Impact factor: 11.528

10.  Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.

Authors:  Stefania Gonfloni; Lucia Di Tella; Sara Caldarola; Stefano M Cannata; Francesca G Klinger; Claudia Di Bartolomeo; Maurizio Mattei; Eleonora Candi; Massimo De Felici; Gerry Melino; Gianni Cesareni
Journal:  Nat Med       Date:  2009-09-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.